What is Darunavir (DRV)?

Category: Prescription Drugs

Most popular types: Prezista

false

Darunavir is a protease inhibitor used in the treatment of HIV-1 infections in combination with ritonavir and other antiretroviral agents.

Reported purpose & perceived effectiveness
Purpose Patients Evaluations Perceived Effectiveness
Human immunodeficiency virus (HIV) 104 46
Acquired immune deficiency syndrome (AIDS) 3 0
Support immune health 3 1
Prevent infection 1 2

  • Major
  • Moderate
  • Slight
  • None
  • Can't tell

Side effects

Side effects as an overall problem

Side effects as an overall problem
Severity Evaluations Percentage
Severe 2
Moderate 5
Mild 11
None 28

Commonly reported side effects and conditions associated with Darunavir (DRV)

Side effect Patients Percentage
Diarrhea 4
Headaches 1
Itching 1
Nausea 1
Tiredness 1
Vivid dreams 1

Dosages

Based on patients currently taking Darunavir (DRV)

Dosage Patients Percentage
800 mg daily 1
600 mg twice daily 1

Why patients stopped taking Darunavir (DRV)

Multiple reasons could be selected

Reason Patients Percentage
Doctor's advice 10
Side effects too severe 6
Course of treatment ended 4
Other 4
Did not seem to work 2
Change in health plan coverage 1
Personal research 1
See all 22 patients who've stopped taking Darunavir (DRV)

Duration

Currently taking Darunavir (DRV)

Duration Patients Percentage
2 - 5 years 1
10 years or more 1

Stopped taking Darunavir (DRV)

Duration Patients Percentage
Less than 1 month 4
1 - 6 months 2
6 months - 1 year 3
1 - 2 years 3
2 - 5 years 5
5 - 10 years 5
Adherence
Adherence Evaluations Percentage
Always 44
Usually 0
Sometimes 1
Never taken as prescribed 1
Burden
Burden Evaluations Percentage
Very hard to take 0
Somewhat hard to take 2
A little hard to take 11
Not at all hard to take 33
Cost per month
Cost per month Evaluations Percentage
$200+ 1
$100-199 0
$50-99 2
$25-49 2
< $25 25
Not specified 16

What people switch to and from

Patients started taking Darunavir (DRV) after stopping:

Treatment Patients Percentage
Cobicistat-elvitegravir-emtricitabine-tenofovir disoproxil (Stribild) 1
Nevirapine (NVP) (Viramune) 1

Patients stopped taking Darunavir (DRV) and switched to:

Treatment Patients Percentage
Dolutegravir (DTG) (Tivicay) 3
Abacavir-lamivudine-zidovudine (ABC/3TC/ZDV) (Trizivir) 1
Darunavir-cobicistat (DRV/c) (Prezcobix) 1
Etravirine (ETR) (Intelence) 1
Raltegravir (RAL) (Isentress) 1

Show all 7 treatments patients report switching to

Last updated:

5 patient evaluations for Darunavir (DRV)

Jul 14, 2016 (Started Aug 29, 2013)

  • Effectiveness
    Major (for human immunodeficiency virus (HIV))
  • Side effects
    None
  • Adherence
    Never taken as prescribed
  • Burden
    Not at all hard to take
Dosage: 1 other Daily
Cost: < $25 monthly

  • 0 helpful marks

Sep 30, 2015 (Started Oct 01, 2010)

  • Effectiveness
    Major (for human immunodeficiency virus (HIV))
  • Effectiveness
    Major (for Prevent infection)
  • Side effects
    None
  • Adherence
    Always
  • Burden
    Not at all hard to take
Dosage: 800 mg Daily
Cost: < $25 monthly

Jun 25, 2011 (Started Oct 01, 2010)

  • Effectiveness
    Moderate (for Prevent infection)
  • Effectiveness
    Major (for human immunodeficiency virus (HIV))
  • Side effects
    Mild
  • Adherence
    Always
  • Burden
    A little hard to take
Dosage: 800 mg Daily
Cost: < $25 monthly

  • 0 helpful marks

Jan 25, 2010 (Started Jan 13, 2010)

  • Effectiveness
    Can't tell (for human immunodeficiency virus (HIV))
  • Side effects
    Severe (skin rash)
  • Adherence
    Sometimes
  • Burden
    A little hard to take
Dosage: 900 mg Daily
Cost: < $25 monthly
Side effects: skin rash

Jan 17, 2010 (Started Jan 13, 2010)

  • Effectiveness
    Major (for human immunodeficiency virus (HIV))
  • Side effects
    None
  • Adherence
    Always
  • Burden
    A little hard to take
Dosage: 900 mg Daily
Advice & Tips: No side effects so far. And those orange pills are so cute!
Cost: < $25 monthly
Side effects: skin rash

  • 0 helpful marks
Last updated:
Showing 3 of 5 patient evaluations for Darunavir (DRV)